Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-23-014148

Options or other derivatives

  • Head of Corporate Development acquired 2,815 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Keeney Adam Head of Corporate Development 2023-05-01 Grant or award · Restricted Stock Unit +2,815 2,815 D
Loading xslF345X04/form4.xml…